Published: 2020-10-28

Clinicopathological study of soft tissue sarcoma-retrospective study of tertiary cancer institute in eastern India

Kunhi Mohammed K. P., Snehasis Pradhan, Supratim Bhattacharyya, Prafulla Kumar Das, Muhammed Navas N. K.


Background: Soft tissue sarcomas are a rare and heterogeneous group of malignant tumors of mesenchymal origin that comprise less than 1 percent of all adult malignancies. Although they occur anywhere in the body, they involve most commonly in extremities, trunk, retroperitoneum and head and neck. The aim of the study was to analyze clinical and histopathological features of various soft tissue sarcomas.

Methods: This was a retrospective study, conducted in tertiary cancer centre in Odisha during the period 2015 to 2018. We collected clinical parameters like age, sex, site of swelling, any associated pain and biopsy reports and these variables were correlated with final histopathology reports.

Results: A total of 107 patients were included in the study, with male to female ratio of 2:1(71 and 36) and average age of 43.45 years. All of them presented with a swelling. The lower extremities were the most common sites i.e. 44.62%. Pleomorphic sarcoma was the most frequent histologic variety comprising 43% and less frequent variety were angiosarcoma, and myxoid sarcoma.

Conclusions: Soft tissue sarcoma are predominant in males and middle aged population are frequently affected. Most common affected site is lower extremity and pleomorphic sarcoma is the prominent histologic type.


Soft tissue sarcoma

Full Text:



Doyle LA, Nascimento AF. Soft Tissue Tumors. Essen Anatomic Pathol. 2011;6:995-1045.

Enzinger FM, Weiss SW. Soft tissue tumors. 3rd edition. Missouri: Mosby Company; 1995.

Gladdy RA, Qin LX, Moraco N. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010;28(12):2064-9.

Bridge JA, Mertens F. Tumor syndromes: introduction. In: Fletcher CDM, Bridge JA, Hogendoorn P, eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th edition. Lyon, France: IARC Press. 2013:14-18.

Levi F, Vecchia CL, Randimbison L. Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland. European J Cancer. 1999;35(12):1711-6.

Pisters PW, Harrison LB, Leung DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14(3):859-68.

Dreinhofer KE, Baldetorp B, Akerman M, Ferno M, Rydholm A, Gustafson P. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow up in 93 patients. Cytometry. 2002;50:19-24.

Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97:2530-43.

Choong PF, Gustafson P, Willén H, Akerman M, Baldetrop B, Fernö M, et al. Prognosis following locally recurrent soft-tissue sarcoma. A staging system based on primary and recurrent tumour characteristics. Int J Cancer. 1995;60:33-7.

Hui JY. Epidemiology and etiology of sarcomas. Surg Clin North Am. 2016;96(5):901-14.

Vodanovich DA, Choong PFM. Soft tissue sarcoma. Indian J Orthop. 2018;52(1):35-44.

Gogi AM, Ramanujam R. Clinicopathological study and management of peripheral soft tissue tumours. J Clin Diagn Res. 2013;7(11):2524-6.

Geer RJ, Woodruff J, Casper ES, Brennan MF. Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg. 1992;127(11):1285-9.

Guillou L, Coindre JM, Bonichon F. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997;15(1):350-62.

Fletcher CD, Gustafson P, Rydholm A. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol. 2001;19(12):3045-50.

Hollowood K, Fletcher CD. Malignant fibrous histiocytoma: morphologic pattern or pathologic entity? Semin Diagn Pathol. 1995;12(3):210-20.

Shukla NK, Deo SV. Soft tissue sarcoma- review of experience at tertiary care cancer center. Indian J Surg Oncol. 2011;2(4):309-12.